UBS Group’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-25,213
| Closed | -$706 | – | 9051 |
|
|
2024
Q2 | $706 | Buy |
25,213
+4,817
| +24% | +$135 | ﹤0.01% | 7645 |
|
|
2024
Q1 | $1.84K | Buy |
20,396
+20,346
| +40,692% | +$1.83K | ﹤0.01% | 6865 |
|
|
2023
Q4 | $5 | Buy |
+50
| New | +$5 | ﹤0.01% | 7944 |
|
|
2023
Q2 | – | Sell |
-8,082
| Closed | -$1.46K | – | 8656 |
|
|
2023
Q1 | $1.46K | Sell |
8,082
-1,272
| -14% | -$229 | ﹤0.01% | 7634 |
|
|
2022
Q4 | $1.87K | Sell |
9,354
-30,999
| -77% | -$6.2K | ﹤0.01% | 8577 |
|
|
2022
Q3 | $29K | Sell |
40,353
-10,223
| -20% | -$7.35K | ﹤0.01% | 5850 |
|
|
2022
Q2 | $27K | Buy |
+50,576
| New | +$27K | ﹤0.01% | 5503 |
|
|
2022
Q1 | – | Sell |
-1,220
| Closed | -$3K | – | 9773 |
|
|
2021
Q4 | $3K | Buy |
1,220
+714
| +141% | +$1.76K | ﹤0.01% | 8581 |
|
|
2021
Q3 | $2K | Buy |
+506
| New | +$2K | ﹤0.01% | 7855 |
|